Management Team

Hong Zhao
President and Chief Executive Officer

Hong Zhao was appointed SciClone President and Chief Executive Officer in November 2013. Mr. Zhao joined SciClone in April 2013. Prior to SciClone, Mr. Zhao served as Executive Vice President of Simcere Pharmaceutical Group, a manufacturer and supplier of pharmaceuticals in China, where he was responsible for all business operations and had direct reporting responsibility for medical affairs, market access, marketing and sales operations, training and personnel development. Prior to Simcere, Mr. Zhao held various positions at Novartis China, a health care products company, including most recently, Senior Vice President of Novartis Greater China and General Manager of Novartis Shanghai. Mr. Zhao earned a Bachelor of Medicine degree from Nanjing Medical College and an Executive Masters of Business Administration degree from China European International Business School (CEIBS) in Shanghai.

Wilson W. Cheung
Chief Financial Officer, Senior Vice President, Finance

Wilson W. Cheung joined SciClone in July 2013 and serves as Chief Financial Officer, Senior Vice President, Finance and Secretary. Prior to joining SciClone, Mr. Cheung served in various positions at Velti plc, a publicly traded global mobile marketing and advertising software-as-a-service provider, including most recently as Chief Compliance Officer, Asia Pacific and previously as Chief Financial Officer. Prior to Velti, Mr. Cheung served as Chief Financial Officer at AXT, Inc., a California-based, publicly traded manufacturer of high performance semiconductor substrates. Mr. Cheung holds a B.A. degree from the University of California, Los Angeles (UCLA), and is a Certified Director of Corporate Governance from UCLA's Executive Program. He is a California Certified Public Accountant (inactive).

Raymond A. Low
Vice President, Finance and Controller

Raymond A. Low joined SciClone as Vice President, Finance and Controller in October 2013. Prior to joining SciClone, Mr. Low served as Chief Financial Officer, and was previously Corporate Controller, at AXT, Inc., a publicly traded manufacturer of high performance semi-conductor substrates. Formerly, Mr. Low was Corporate Controller of Therasense, Inc. (now Abbott Laboratories), a health care products company. Mr. Low is a California certified public accountant, and a member of the California Society of CPAs. He is a past member of the Chartered Institute of Management Accountants in the United Kingdom. Mr. Low has an M.B.A. degree from Chadwick University, Alabama, a Bachelor of Accounting Science Honors degree from the University of South Africa, and a Bachelor of Commerce degree from Rhodes University, South Africa.

Lan Xie
Vice President, Finance and Chief Financial Officer, China Operations

Lan Xie joined SciClone as Vice President, Finance, China Chief Financial Officer in 2012. Ms. Xie served as Vice President of Finance and Investor Relations at Shangpharma Corporation, a pharmaceutical company. Ms. Xie served as a senior manager, transaction services, at PriceWaterhouseCoopers Zhong Tian LLP in Shanghai, and previously served as manager, mergers and acquisitions at Deloitte & Touche in New York. She is a Massachusetts certified public accountant and received her MBA from INSEAD, Singapore/France.

© 2017 SciClone Pharmaceuticals, Inc. All rights reserved. Please read our disclaimer. Terms of Use | Notes Regarding Forward Looking Statements